Canvas Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$656K Buy
2,605
+461
+22% +$99.2K 0.09% 112
2026
Q1
$466K Sell
2,144
-110
-5% -$24.4K 0.08% 135
2025
Q4
$515K Sell
2,254
-231
-9% -$52.6K 0.09% 119
2025
Q3
$581K Buy
2,485
+3
+0.1% +$611 0.11% 99
2025
Q2
$468K Buy
2,482
+129
+5% +$24K 0.09% 116
2025
Q1
$409K Buy
2,353
+7
+0.3% +$1.36K 0.11% 113
2024
Q4
$417K Buy
2,346
+1
+0% +$184 0.1% 107
2024
Q3
$463K Buy
2,345
+1,169
+99% +$218K 0.13% 97
2024
Q2
$220K Buy
+1,176
New +$195K 0.07% 139
2024
Q1
Sell
-1,273
Closed -$207K 147
2023
Q4
$207K Sell
1,273
-125
-9% -$18.2K 0.08% 121
2023
Q3
$204K Buy
+1,398
New +$205K 0.08% 118
2023
Q2
Sell
-1,464
Closed -$218K 129
2023
Q1
$218K Buy
+1,464
New +$224K 0.09% 129
2022
Q1
Sell
-2,873
Closed -$389K 143
2021
Q4
$389K Buy
2,873
+646
+29% +$76.3K 0.14% 101
2021
Q3
$240K Sell
2,227
-460
-17% -$52.6K 0.1% 107
2021
Q2
$303K Buy
2,687
+613
+30% +$69K 0.14% 94
2021
Q1
$225K Buy
+2,074
New +$222K 0.13% 103

Other funds holding ABBV

Canvas Wealth Advisors's ABBV Position: Q2 2026 in Review

Canvas Wealth Advisors increased its AbbVie (ABBV) stake by 22% in Q2 2026, buying an estimated $99.2K and bringing the position to 2,605 shares worth $656K. The position accounts for 0.09% of the portfolio, ranked #112.

Canvas Wealth Advisors first reported a position in ABBV in Q1 2021 and has held it in 16 quarters since. 1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Canvas Wealth Advisors held 2,605 shares of AbbVie worth $656K as of Q2 2026.
  • Canvas Wealth Advisors bought 461 AbbVie shares in Q2 2026, an estimated $99.2K.
  • AbbVie made up 0.09% of Canvas Wealth Advisors's portfolio in Q2 2026, its #112 holding.
  • Canvas Wealth Advisors first reported a position in AbbVie in Q1 2021 and has held it in 16 quarters since.
  • 1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Canvas Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.